A WORLDWIDE, PHASE III, RANDOMIZED, CONTROLLED, SAFETY AND EFFICACY STUDY OF A SIROLIMUS/CYCLOSPORINE REGIMEN FOR PREVENTION OF ACUTE REJECTION IN RECIPIENTS OF PRIMARY MISMATCHED RENAL ALLOGRAFTS
By A. Macdonald. Transplantation, 2001
622 citations recorded by the source corpus.
Subfields: Molecular Biology, Public Health, Environmental and Occupational Health, Transplantation
View Paper: https://www.semanticscholar.org/paper/a69ba59522f453aa6a8c8e88b6a18cb29c3d5224
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Public Health, Environmental and Occupational Health
In Transplantation
Citations in the corpus
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease. (2006, background): “Anemia was a significant AE in a phase III rial in which sirolimus was administered with yclosporine and corticosteroids.(417) A group eviewed the 10-year experience with sirolius and reported a dose-dependent associaion of anemia with the drug in phase I and II rials.”